Table 1 Immunohistochemistry analysis of BTN2A1 and BTN3A1 expression in tumor tissue samples of glioma patients with different responses to Vγ9Vδ2 T therapy
Antitumor effect on PTCs | Total patients (n) | BTN2A1 Expression | BTN3A1 Expression | BTN2A1 + BTN3A1 expression | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Positive (n) | Negative (n) | Positive Rate (%) | Positive (n) | Negative (n) | Positive Rate (%) | Positive (n) | Negative (n) | Positive Rate (%) | P value* | ||
SAT | 6 | 6 | 0 | 100 | 6 | 0 | 100 | 6 | 0 | 100 | 0.00012 |
WAT | 20 | 3 | 17 | 15 | 5 | 15 | 25 | 3 | 17 | 15 | |